iGEM is an international competition in the field of synthetic biology, which was initiated by the Massachusetts Institute of Technology (MIT) in Boston. The competition aims to inspire the development of innovative and intelligent solutions for relevant and recent problems through genetic modifications.
This year's iGEM Team Tübingen consists of 15 students of biochemistry, biotechnology, chemistry, bioinformatics, molecular medicine and nanoscience. The aim of the project 2019 is to generate a probiotic for the therapy of Type II Diabetes Mellitus, based on a plasmid chassis incorporating a Cas3 self-kill mechanism to prevent the spread of GMOs (Genetically Modified Organism) in the environment.
If you want to learn more about iGEM, Team Tübingen and our project, visit our website: